Dark Forest Capital Management’s Ocular Therapeutix OCUL Stock Holding History

Dark Forest Capital Management’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-105,627	Closed	-$1.28M	–	1037
2025 Q4	$1.28M	Buy	105,627 +22,188	+27%	+$270K	0.06%	566
2025 Q3	$975K	Sell	83,439 -78,464	-48%	-$938K	0.04%	750
2025 Q2	$1.5M	Buy	+161,903	New	+$1.27M	0.06%	575
2024 Q3	–	Sell	-12,383	Closed	-$84.7K	–	1098
2024 Q2	$84.7K	Sell	12,383 -8,011	-39%	-$49.5K	0.02%	626
2024 Q1	$186K	Buy	+20,394	New	+$145K	0.03%	635
2022 Q1	–	Sell	-194	Closed	-$1K	–	1616
2021 Q4	$1K	Sell	194 -1,993	-91%	-$15.5K	﹤0.01%	1348
2021 Q3	$212K	Buy	+2,187	New	+$24.6K	0.08%	223

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dark Forest Capital Management's OCUL Position: Q1 2026 in Review

Dark Forest Capital Management sold out of Ocular Therapeutix (OCUL) in Q1 2026, closing a stake of 105,627 shares — an estimated $1.28M sold.

Dark Forest Capital Management first reported a position in OCUL in Q3 2021 and held it in 7 quarters. The position peaked at $1.5M in Q2 2025. 270 funds tracked by Wall St. Rank hold OCUL as of Q1 2026.

Dark Forest Capital Management reported no remaining Ocular Therapeutix position as of Q1 2026 after selling out during the quarter.
Dark Forest Capital Management sold 105,627 Ocular Therapeutix shares in Q1 2026, an estimated $1.28M.
Dark Forest Capital Management first reported a position in Ocular Therapeutix in Q3 2021 and held it in 7 quarters.
Dark Forest Capital Management's Ocular Therapeutix position peaked at $1.5M in Q2 2025.
270 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.